Bahrain’s NHRA Issues Additional List of Safe Diabetes Medicines

by BTM

Tue, 09 June 2020

Bahrain’s NHRA Issues Additional List of Safe Diabetes Medicines

The National Health Regulatory Authority (NHRA) has released an additional list that includes the safe diabetes medicines containing Metformin, and free from the carcinogenic impurity (NDMA) or its presences within the acceptable limits on its website.

The list contains the drugs' names, registration numbers and the names of the manufacturers.

Last week, the Ministry of Health and the National Health Regulatory Authority issued a joint statement, in which they confirmed that citizens need not worry about pharmaceuticals used for treating people with diabetes containing Metformin, and that the decision to continue or change a patient’s drug was the responsibility of the attending physician.

The Health Ministry and the NHRA have requested all diabetes patients to consult their doctors should they want to change medication and select the appropriate alternatives.

The statement said that the NHRA was awaiting the results of an investigation during the next few days in order to issue another list of approved medicines, according to the report of the manufacturers and results of the analysis.

 The NHRA renewed its call to patients to review its website to see if their medications were still included in the list of approved drugs, and to consult their doctors if their medicines were not mentioned.

For more news and updates, click here: